ZNF765 is a prognostic biomarker of hepatocellular carcinoma associated with cell cycle, immune infiltration, m6A modification, and drug susceptibility-Reference-Cited by-同舟云学术

ZNF765 is a prognostic biomarker of hepatocellular carcinoma associated with cell cycle, immune infiltration, m6A modification, and drug susceptibility

Published:2023-07-04 Issue:13 Volume:15 Page:6179-6211
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Ding Yongqi¹²,Gong Yiyang²,Zeng Hong²,Song Gelin²,Yu Zichuan²,Fu Bidong²,Liu Yue²,Huang Da³,Zhong Yanying⁴

Affiliation:

1. Second Affiliated Hospital of Nanchang University, Nanchang, China

2. Second College of Clinical Medicine, Nanchang University, Nanchang, China

3. Department of Thyroid Surgery, Second Affiliated Hospital of Nanchang University, Nanchang, China

4. Department of Obstetrics and Gynecology, Second Affiliated Hospital of Nanchang University, Nanchang, China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Reference70 articles.

1. Collagen 1A1 (COL1A1) Is a Reliable Biomarker and Putative Therapeutic Target for Hepatocellular Carcinogenesis and Metastasis.;Lee;Cancers (Basel),2019

2. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study.;Asgedom;JAMA Oncol,2018

3. Association of Provider Specialty and Multidisciplinary Care With Hepatocellular Carcinoma Treatment and Mortality.;Kaplan;Gastroenterology,2017

4. Comparison of treatment efficacy and safety between drug-eluting bead transarterial chemoembolization with CalliSpheres® microspheres and conventional transarterial chemoembolization as first-line treatment in hepatocellular carcinoma patients.;Xiong;Am J Transl Res,2019